Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Calza

Showing results (11-20 of 188) with videos related to

Pageof 19
Sort By:
European Journal of Preventive Cardiology|June 24, 2017
Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it?Francesco Grigioni, Leonardo Calza
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
HIV genotype mutations evoked by nelfinavir-based regimens: frequency, background, and consequences on subsequent treatment optionsRoberto Manfredi, Leonardo Calza
International Journal of STD & AIDS|March 13, 2008
HIV infection and the pancreas: risk factors and potential management guidelinesRoberto Manfredi, Leonardo Calza
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 7, 2007
Severe brain co-infection with Cryptococcus neoformans and Mycobacterium tuberculosis in a young, otherwise healthy student recently immigrated from ChinaRoberto Manfredi, Leonardo Calza
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2007
Safety issues about nevirapine administration in HIV-infected pregnant womenRoberto Manfredi, Leonardo Calza
Presse Medicale (Paris, France : 1983)|April 26, 2003
[Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART)]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
AIDS (London, England)|March 28, 2003
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAARTLeonardo Calza, Roberto Manfredi, Francesco Chiodo
AIDS Patient Care and Stds|May 2, 2003
Prospective comparison of first-line nelfinavir therapy versus nelfinavir introduction in rescue antiretroviral regimensRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|October 12, 2004
[Tick-borne infections]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
HIV Clinical Trials|February 3, 2006
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapineRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Pageof 19

Showing results (11-20 of 188) with videos related to

Sort By:
Pageof 19
European Journal of Preventive Cardiology|June 24, 2017
Cardiovascular prevention in HIV-positive individuals on antiretroviral therapy.. The paradigm shift has already happened: Is it time to wake up and realise it?Francesco Grigioni, Leonardo Calza
Journal of Acquired Immune Deficiency Syndromes (1999)|June 5, 2002
HIV genotype mutations evoked by nelfinavir-based regimens: frequency, background, and consequences on subsequent treatment optionsRoberto Manfredi, Leonardo Calza
International Journal of STD & AIDS|March 13, 2008
HIV infection and the pancreas: risk factors and potential management guidelinesRoberto Manfredi, Leonardo Calza
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 7, 2007
Severe brain co-infection with Cryptococcus neoformans and Mycobacterium tuberculosis in a young, otherwise healthy student recently immigrated from ChinaRoberto Manfredi, Leonardo Calza
Journal of Acquired Immune Deficiency Syndromes (1999)|June 27, 2007
Safety issues about nevirapine administration in HIV-infected pregnant womenRoberto Manfredi, Leonardo Calza
Presse Medicale (Paris, France : 1983)|April 26, 2003
[Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART)]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
AIDS (London, England)|March 28, 2003
Statins and fibrates for the treatment of hyperlipidaemia in HIV-infected patients receiving HAARTLeonardo Calza, Roberto Manfredi, Francesco Chiodo
AIDS Patient Care and Stds|May 2, 2003
Prospective comparison of first-line nelfinavir therapy versus nelfinavir introduction in rescue antiretroviral regimensRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Recenti Progressi in Medicina|October 12, 2004
[Tick-borne infections]Leonardo Calza, Roberto Manfredi, Francesco Chiodo
HIV Clinical Trials|February 3, 2006
Prospective, open-label comparative study of liver toxicity in an unselected population of HIV-infected patients treated for the first time with efavirenz or nevirapineRoberto Manfredi, Leonardo Calza, Francesco Chiodo
Pageof 19